» Articles » PMID: 37236991

Nationwide Analysis of Hospital Admissions and Outcomes of Patients with SARS-CoV-2 Infection in Austria in 2020 and 2021

Overview
Journal Sci Rep
Specialty Science
Date 2023 May 26
PMID 37236991
Authors
Affiliations
Soon will be listed here.
Abstract

This retrospective study evaluated temporal and regional trends of patient admissions to hospitals, intensive care units (ICU), and intermediate care units (IMCU) as well as outcomes during the COVID-19 pandemic in Austria. We analysed anonymous data from patients admitted to Austrian hospitals with COVID-19 between January 1st, 2020 and December 31st, 2021. We performed descriptive analyses and logistic regression analyses for in-hospital mortality, IMCU or ICU admission, and in-hospital mortality following ICU admission. 68,193 patients were included, 8304 (12.3%) were primarily admitted to ICU, 3592 (5.3%) to IMCU. Hospital mortality was 17.3%; risk factors were male sex (OR 1.67, 95% CI 1.60-1.75, p < 0.001) and high age (OR 7.86, 95% CI 7.07-8.74, p < 0.001 for 90+ vs. 60-64 years). Mortality was higher in the first half of 2020 (OR 1.15, 95% CI 1.04-1.27, p = 0.01) and the second half of 2021 (OR 1.11, 95% CI 1.05-1.17, p < 0.001) compared to the second half of 2020 and differed regionally. ICU or IMCU admission was most likely between 55 and 74 years, and less likely in younger and older age groups. We find mortality in Austrian COVID-19-patients to be almost linearly associated with age, ICU admission to be less likely in older individuals, and outcomes to differ between regions and over time.

Citing Articles

In-hospital mortality, comorbidities, and costs of one million mechanically ventilated patients in Germany: a nationwide observational study before, during, and after the COVID-19 pandemic.

Karagiannidis C, Krause F, Bentlage C, Wolff J, Bein T, Windisch W Lancet Reg Health Eur. 2024; 42:100954.

PMID: 39070745 PMC: 11281923. DOI: 10.1016/j.lanepe.2024.100954.


Risk of severe COVID-19 in unvaccinated patients during the period from wild-type to Omicron variant: real-world evidence from Japan.

Tomioka K, Uno K, Yamada M Environ Health Prev Med. 2024; 29:10.

PMID: 38447970 PMC: 10937246. DOI: 10.1265/ehpm.23-00274.

References
1.
Tan E, Song J, Deane A, Plummer M . Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis. Chest. 2020; 159(2):524-536. PMC: 7557272. DOI: 10.1016/j.chest.2020.10.014. View

2.
Navaratnam A, Gray W, Day J, Wendon J, Briggs T . Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data. Lancet Respir Med. 2021; 9(4):397-406. PMC: 7906650. DOI: 10.1016/S2213-2600(20)30579-8. View

3.
Grosgurin O, Leidi A, Darbellay Farhoumand P, Carballo S, Adler D, Reny J . Role of Intermediate Care Unit Admission and Noninvasive Respiratory Support during the COVID-19 Pandemic: A Retrospective Cohort Study. Respiration. 2021; 100(8):786-793. PMC: 8247832. DOI: 10.1159/000516329. View

4.
Moreno R, Metnitz P, Almeida E, Jordan B, Bauer P, Abizanda Campos R . SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005; 31(10):1345-55. PMC: 1315315. DOI: 10.1007/s00134-005-2763-5. View

5.
Chang R, Elhusseiny K, Yeh Y, Sun W . COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis. PLoS One. 2021; 16(2):e0246318. PMC: 7877631. DOI: 10.1371/journal.pone.0246318. View